Ataxin 3 Antikörper (AA 1-215)
Kurzübersicht für Ataxin 3 Antikörper (AA 1-215) (ABIN1885789)
Target
Alle Ataxin 3 (ATXN3) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-215
-
Aufreinigung
- Purified by antigen-affinity chromatography.
-
Immunogen
- Recombinant protein fragment contain a sequence corresponding to a region within amino acids 1 and 215 of Ataxin 3
-
-
-
-
Applikationshinweise
-
Suggested dilutions:
Western blotting: 1.500-1.3000
Immunohistochemistry: 1.100-1.500 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 20 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Konservierungsmittel
- Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- Ataxin 3 (ATXN3)
-
Andere Bezeichnung
- Ataxin 3
-
Hintergrund
-
Machado-Joseph disease, also known as spinocerebellar ataxia-3, is an autosomal dominant neurologic disorder.The protein encoded by this gene contains (CAG)n repeats in the coding region, and the expansion of these repeats from the normal 13-36 to 68-79 is the cause of Machado-Joseph disease.There is a negative correlation between the age of onset and CAG repeat numbers.Alternatively spliced transcript variants encoding different isoforms have been described for this gene.[provided by RefSeq]
-
Molekulargewicht
- 42 kDa
-
Gen-ID
- 4287
Target
-